全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Alain Lortholary , Catherine Noguès ...
来源:[J].Disease Markers(IF 2.14), 1999, Vol.15 (1-3), pp.15-29DOAJ
摘要:AIM: In order to evaluate the characteristics and the evolution of cancer genetics activity in France, a survey was conducted at the national level during a period of 4 years from 1994 to 1997 through the French Cooperative Network, a multidisciplinary group formed to investigate...
作者:Alain Lortholary , Catherine Noguès ...
来源:[J].Disease Markers(IF 2.14), 2013, Vol.15 (1-3)Hindawi
摘要:AIM: In order to evaluate the characteristics and the evolution of cancer genetics activity in France, a survey was conducted at the national level during a period of 4 years from 1994 to 1997 through the French Cooperative Network, a multidisciplinary group formed to investigate...
作者:Alain Lortholary , Joseph Gligorov ...
来源:[J].Bulletin du Cancer(IF 0.605), 2014, Vol.101 (9), pp.780-788Elsevier
摘要:Abstract(#br)The international phase IIIb study, ATHENA assessed the combination of bevacizumab/taxane-based chemotherapy in the first-line treatment of HER2negative metastatic breast cancer (mBC) in real-life setting. Among the 365patients included in France, median overall surv...
作者:Alain Lortholary , David Khayat ...
来源:[J].European Journal of Cancer(IF 5.061), 2015, Vol.51 (13), pp.1660-1666Elsevier
摘要:Abstract(#br)Background(#br)This article reports, the cardiac toxicity according to 6- versus 12-month durations of adjuvant trastuzumab in PHARE randomised trial (NCT00381901).(#br)Patients and methods(#br)Cardiac follow-up and Left Ventricular Ejection Fraction (LVEF) assessmen...
作者:Alain Lortholary , Yacine Merrouche ...
来源:[J].Oncologie(IF 0.097), 2007, Vol.9 (4), pp.313-316Springer
摘要:Abstract(#br) Context(#br)The validity of clinical practice guidelines is based on their regular update as well as the quality of the initial guideline development process. The Standards, options and recommendations (SOR) of the French National Federation of Comprehensive Ca...
作者:Alain Lortholary , Maria Pavlyuk ...
来源:[J].Bulletin du Cancer(IF 0.605), 2012, Vol.99 (6), pp.609-618Elsevier
摘要:Abstract(#br)The efficacy of the combination bevacizumab-chemotherapy in the first-line treatment of metastatic breast cancer (mBC) was demonstrated in several randomized clinical trials. However, limited safety data is available in daily medical practice. ATHENA is an internatio...
作者:Alain Lortholary , Claude El Kouri ...
来源:[J].Bulletin du Cancer(IF 0.605), 2013, Vol.100 (3), pp.247-257Elsevier
摘要:Abstract(#br)Purpose(#br)To explore patient and nurse satisfaction, compliance with best practice, technical feasibility and safety of home infusion of a bisphosphonate.(#br)Methods(#br)Prospective 1-year survey of home zoledronic acid therapy (4 mg, 15-min intraveinous, every th...
作者:Alain Lortholary , Marc Espié ...
来源:[J].Lancet Oncology(IF 25.117), 2013, Vol.14 (8), pp.741-748Elsevier
摘要:Summary(#br)Background(#br)Since 2005, 12 months of adjuvant trastuzumab has been the standard treatment for patients with HER2-positive early-stage breast cancer. However, the optimum duration of treatment has been debated. We did a non-inferiority trial of a shorter exposu...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×